Skip to content

The Effects of Body Scan on Enteroception in Patients With Heart Failure

The Effects of Body Scan on Enteroception in Patients With Heart Failure: a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06737679
Acronym
SCAN-HF
Enrollment
110
Registered
2024-12-17
Start date
2025-01-28
Completion date
2026-01-31
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart failure, Enteroception, Body scan, Mindfullness, Self-care monitoring

Brief summary

The study aims to explore the effects of body scan on enteroception in people with heart failure

Interventions

BEHAVIORALBody Scan

Body scan is a guided meditation technique that allows people to detect signs and signals from their body (for instance, heart rate). The intervention will last 20 minutes and will be performed 21 consecutives days. The first and last days it will be performed in presence, while the other ones online.

Sponsors

University of Rome Tor Vergata
CollaboratorOTHER
Bicocca Universiy of Milano, Milan, Italy
CollaboratorUNKNOWN
American Holistic Nurses Association (AHNA)
CollaboratorUNKNOWN
Centro Cardiologico Monzino
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Heart Failure * Italian speaking * Willing to sign the Informed Consent Form

Exclusion criteria

* Cognitive Impairment documented in the medical records

Design outcomes

Primary

MeasureTime frameDescription
Enteroceptive sensibilityAt 1 month after the end of the body scan interventionEnteroceptive Sensibility (assessed with the Multidimensional Assessment of Interoceptive Awareness, version 2, MAIA-2) The MAIA-2 is a 6-point Likert scale questionnaire with 37 items divided into 8 subscales. Higher scores reflect greater enteroceptive sensibility.

Secondary

MeasureTime frameDescription
Enteroceptive AccuracyAt baseline, 1, 3, 6, and 9 months after the end of the interventionEnteroceptive Accuracy (assessed with the Heartbeat Tracking Task)
Enteroceptive AwarenessAt baseline, after 1, 3, 6, and 9 months after the end of the interventionEnteroceptive Awareness will be calculated with Pearson's r confidence, using the HTT score as a measure of interoceptive accuracy and a confidence VAS (0-10) as a partial measure of interoceptive sensibility
Symptoms PerceptionAt baseline, 1, 3, 6, and 9 months after the end of the interventionSymptom Perception (assessed with the Heart Failure Somatic Perception Scale), which is a 6-point Likert scale with 18 items. Higher scores reflect a higher impact of heart failure on patients' lives.
Generic Quality of LifeAt baseline, 1, 3, 6, and 9 months after the end of the interventionQuality of Life wil be assessed with the 5-dimensions version of EuroQoL (EQ-5D). The EuroQoL is a standardized measure of health status divided into two sections: section one comprises 5 dimensions (Mobility, Self-Care, Usual Activities, Pain/Discomfort, Anxiety/Depression) and 3 levels (no problems, some problems, extreme problems); section two asks participants to rank their perceived health status with a VAS ranging from 0 ('The worst health you can imagine') to 100 ('The best health you can imagine').
Heart Failure Specific Quality of LifeAt baseline, 1, 3, 6, and 9 months after the end of the interventionHeart Failure Specific Quality of Life will be measured using the 12-Items Kansas City Cardiomyopathy Questionnaire (KCCQ). The KCCQ comprises 12 items exploring 4 dimensions. Scores range from 0 to 100, where 100 reflects a higher functioning level.
Enteroceptive SensibilityAt 3, 6, and 9 month after the end of the interventionEnteroceptive Sensibility (assessed with Multidimensional Assessment of Interoceptive Awareness, version 2, MAIA-2) MAIA-2 is a 6-point Likert scale questionnaire with 37 items divided into 8 subscales. Higher scores reflect greater interoception
Self-care Self-efficacyAt baseline, 1, 3, 6, and 9 months after the end of the interventionSelf-care Self-efficacy will be assessed using the Self-Care Self-Efficacy Scale, which comprises 10 items, answerable from a 1 to 5 option-scale. Scores are standardized to range from 0 to 100, with higher scores representing higher levels of self-efficacy.
AnxietyAt baseline, 1, 3, 6, and 9 months after the end of the interventionAnxiety (assessed with the State-Trait Anxiety Inventory Form Y, STAI-Y) The State-Trait Anxiety Inventory Form Y (STAI-Y) is a validated questionnaire divided into two scales measuring state and trait anxiety, respectively. Both STAI-S and STAI-T comprise 20 items each, for a total of 40 items. Items are rated on a 4-point scale, with higher scores reflecting greater anxiety levels
DepressionAt baseline, 1, 3, 6, and 9 months after the end of the interventionDepression will be measured with the Beck Depression Inventory-II (BD-II). It has 21 items, answerable on a 4-point Likert scale ranging from 0 to 3. Higher scores indicate greater severity of depression symptoms
AlexithymiaAt baseline, 1, 3, 6, and 9 months after the end of the interventionAlexithymia will be assessed using the 20-item Toronto Alexithymia Scale (TAS-20). It comprises 3 factors, answerable with a 5-point Likert scale, with increasing scores indicating higher degrees of alexithymia.
Emotional RegulationAt baseline, 1, 3, 6, and 9 months after the end of the interventionEmotional Regulation will be assessed with the Emotional Regulation Questionnaire (ERQ). ERQ is a 10-item self-report questionnaire, rated on a 7-point Likert scale from 1 ('Strongly Disagree') to 7 ('Strongly Agree'), with higher scores indicating higher emotional regulation
Self-careAt baseline, 1, 3, 6, and 9 months after the end of the interventionSelf-care will be assessed with the Self-Care of Heart Failure Index version 7.2. It is a 29-item instrument exploring three dimensions with 5-point Likert-type options. Higher scores reflect better self-care

Countries

Italy

Contacts

Primary ContactAlessia M Trenta, Dr
alessia.trenta@cardiologicomonzino.it00390258002445

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026